These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7487385)

  • 1. Exploring the medical need for alternate site testing. A clinician's perspective.
    Becker RC
    Arch Pathol Lab Med; 1995 Oct; 119(10):894-7. PubMed ID: 7487385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsibilities in point-of-care testing. An institutional perspective.
    Lamb LS
    Arch Pathol Lab Med; 1995 Oct; 119(10):886-9. PubMed ID: 7487383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. College of American Pathologists Conference XXVIII on alternate site testing: keynote address. Global view of how alternate site testing fits in with medical care.
    O'Leary D
    Arch Pathol Lab Med; 1995 Oct; 119(10):877-80. PubMed ID: 7487381
    [No Abstract]   [Full Text] [Related]  

  • 5. College of American Pathologists Conference XXVIII on alternate site testing: introduction.
    Handorf CR
    Arch Pathol Lab Med; 1995 Oct; 119(10):867-73. PubMed ID: 7487378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for a point of care testing: an evidence-based appraisal.
    Collinson PO
    Scand J Clin Lab Invest Suppl; 1999; 230():67-73. PubMed ID: 10389204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care testing reduces length of stay in emergency department chest pain patients.
    Singer AJ; Ardise J; Gulla J; Cangro J
    Ann Emerg Med; 2005 Jun; 45(6):587-91. PubMed ID: 15940089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing.
    Kilgore ML; Steindel SJ; Smith JA
    J Healthc Manag; 1999; 44(3):207-15. PubMed ID: 10537498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial justification of alternate site testing.
    De Cresce RP; Phillips DL; Howanitz PJ
    Arch Pathol Lab Med; 1995 Oct; 119(10):898-901. PubMed ID: 7487386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful alternatives to alternate site testing. Use of a pneumatic tube system to the central laboratory.
    Green M
    Arch Pathol Lab Med; 1995 Oct; 119(10):943-7. PubMed ID: 7487396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate site testing. The old and new paradigm or the past is prologue.
    Bachner P
    Arch Pathol Lab Med; 1995 Oct; 119(10):881-5. PubMed ID: 7487382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mobile laboratory in alternative site testing.
    Fuhrman SA; Travers EM; Handorf CR
    Arch Pathol Lab Med; 1995 Oct; 119(10):939-42. PubMed ID: 7487395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-Care Testing and Cardiac Biomarkers: The Standard of Care and Vision for Chest Pain Centers.
    Kost GJ; Tran NK
    Cardiol Clin; 2005 Nov; 23(4):467-90, vi. PubMed ID: 16278118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undertaking an information-needs analysis of the emergency-care physician to inform the role of the clinical librarian: a Greek perspective.
    Lappa E
    Health Info Libr J; 2005 Jun; 22(2):124-32. PubMed ID: 15910583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit.
    Apple FS; Chung AY; Kogut ME; Bubany S; Murakami MM
    Clin Chim Acta; 2006 Aug; 370(1-2):191-5. PubMed ID: 16545790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a 6-hour and 9-hour protocol for evaluation of moderate-to-low risk chest pain patients in an emergency department diagnostic unit.
    Lateef F; Storrow AB; Malone K; Liu T; Gibler BW
    Singapore Med J; 2001 Feb; 42(2):52-6. PubMed ID: 11358190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. College of American Pathologists Conference XXVIII on alternate site testing. What must we now do?
    Howanitz PJ
    Arch Pathol Lab Med; 1995 Oct; 119(10):979-83. PubMed ID: 7487399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study.
    Apple FS; Jaffe AS
    Circulation; 2001 Nov; 104(22):E125-6. PubMed ID: 11723038
    [No Abstract]   [Full Text] [Related]  

  • 19. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain?
    Rathore S; Knowles P; Mann AP; Dodds PA
    Eur J Intern Med; 2008 Nov; 19(7):537-40. PubMed ID: 19013384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.